1 Firestein, GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356–361.
2 Feldmann, M & Maini, RN (1999) The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatol 38, Suppl. 2, 3–7.
3 Calder, PC (2008) PUFA, inflammatory processes and rheumatoid arthritis. Proc Nutr Soc 67, 409–418.
4 Sweeney, SE & Firestein, GS (2004) Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 36, 372–378.
5 Bowes, J & Barton, A (2008) Recent advances in the genetics of RA susceptibility. Rheumatol 47, 399–402.
6 Panayi, GS (1999) Targetting of cells involved in the pathogenesis of rheumatoid arthritis. Rheumatol 38, Suppl. 2, 8–10.
7 Tilley, SL, Coffman, TM & Koller, BH (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108, 15–23.
8 Calder, PC (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
9 Sano, H, Hla, T, Maier, JAM, et al. (1992) In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89, 97–108.
10 Sperling, RI (1995) Eicosanoids in rheumatoid arthritis. Rheum Dis Clin N Am 21, 741–758.
11 Lee, TH, Hoover, RL, Williams, JD, et al. (1985) Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Eng J Med 312, 1217–1224.
12 Endres, S, Ghorbani, R, Kelley, VE, et al. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Eng J Med 320, 265–271.
13 Sperling, RI, Benincaso, AI, Knoell, CT, et al. (1993) Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91, 651–660.
14 Gibney, MJ & Hunter, B (1993) The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 47, 255–259.
15 Caughey, GE, Mantzioris, E, Gibson, RA, Cleland, LG & James, MJ (1996) The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63, 116–122.
16 Yaqoob, P, Pala, HS, Cortina-Borja, M, Newsholme, EA & Calder, PC (2000) Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 30, 260–274.
17 Healy, DA, Wallace, FA, Miles, EA, Calder, PC & Newsholme, P (2000) The effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 35, 763–768.
18 Thies, F, Nebe-von-Caron, G, Powell, JR, et al. (2001) Dietary supplementation with γ-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 131, 1918–1927.
19 Kew, S, Banerjee, T, Minihane, AM, et al. (2003) Relation between the fatty acid composition of peripheral blood mononuclear cells and measures of immune cell function in healthy, free-living subjects aged 25–72 y. Am J Clin Nutr 77, 1278–1286.
20 Kew, S, Mesa, MD, Tricon, S, et al. (2004) Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 79, 674–681.
21 Rees, D, Miles, EA, Banerjee, T, et al. (2006) Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 83, 331–342.
22 Faber, J, Berkhout, M, Vos, AP, et al. (2011) Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women. J Nutr 141, 964–970.
23 Calder, PC (2008) The relationship between the fatty acid composition of immune cells and their function. Prostagland Leukotr Essent Fatty Acids 79, 101–108.
24 Meydani, SN, Endres, S, Woods, MM, et al. (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 121, 547–555.
25 Von Schacky, C, Kiefl, R, Jendraschak, E & Kaminski, WE (1993) N-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo and in vivo. J Lab Clin Med 121, 302–309.
26 Kremer, JM, Bigauoette, J, Michalek, AV, et al. (1985) Effects of manipulation of dietary fatty acids on manifestations of rheumatoid arthritis. Lancet i, 184–187.
27 Kremer, JM, Jubiz, W, Michalek, A, et al. (1987) Fish-oil supplementation in active rheumatoid arthritis. Ann Int Med 106, 497–503.
28 Kremer, JM, Lawrence, DA, Jubiz, W, et al. (1990) Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arth Rheum 33, 810–820.
29 Sperling, RI, Weinblatt, M, Robin, JL, et al. (1987) Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arth Rheum 30, 988–997.
30 Cleland, LG, French, JK, Betts, WH, Murphy, GA & Elliot, MJ (1988) Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 15, 1471–1475.
31 van der Tempel, H, Tullekan, JE, Limburg, PC, Muskiet, FAJ & van Rijswijk, MH (1990) Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 49, 76–80.
32 Cleland, LG, Caughey, GE, James, MJ & Proudman, SM (2006) Reduction of cardiovascular risk factors with long term fish oil treatment in early rheumatoid arthritis. J Rheumatol 33, 1973–1979.
33 Goldman, DW, Pickett, WC & Goetzl, EJ (1983) Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun 117, 282–288.
34 Lee, TH, Mencia-Huerta, JM, Shih, C, et al. (1984) Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene-B5 and the double lipoxygenase product. J Biol Chem 259, 2383–2389.
35 Bagga, D, Wang, L, Farias-Eisner, R, Glaspy, JA & Reddy, ST (2003) Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 100, 1751–1756.
36 Tull, SP, Yates, CM, Maskrey, BH, et al. (2009) Omega-3 Fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment. PLoS Biol 7, e1000177.
37 Serhan, CN, Clish, CB, Brannon, J, et al. (2000) Anti-inflammatory lipid signals generated from dietary n-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and n-3 PUFA therapeutic actions. J Physiol Pharmacol 4, 643–654.
38 Serhan, CN, Clish, CB, Brannon, J, et al. (2000) Novel functional sets of lipid-derived mediators with antinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192, 1197–1204.
39 Serhan, CN, Hong, S, Gronert, K, et al. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med 196, 1025–1037.
40 Hong, S, Gronert, K, Devchand, P, Moussignac, R-L & Serhan, CN (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autocoids in anti-inflammation. J Biol Chem 278, 14677–14687.
41 Marcheselli, VL, Hong, S, Lukiw, WJ & Hua Tian, X (2003) Novel docosanoids inhibit brain ischemia reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278, 43807–43817.
42 De Caterina, R, Cybulsky, MI, Clinton, SK, Gimbrone, MA & Libby, P (1994) The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14, 1829–1836.
43 Khalfoun, B, Thibault, F, Watier, H, et al. (1997) Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Biol Med 400, 589–597.
44 Lo, CJ, Chiu, KC, Fu, M, Lo, R & Helton, S (1999) Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res 82, 216–221.
45 Babcock, TA, Novak, T, Ong, E, et al. (2002) Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J Surg Res 107, 135–139.
46 Novak, TE, Babcock, TA, Jho, DH, Helton, WS & Espat, NJ (2003) NF-k kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol 284, L84–L89.
47 Zhao, Y, Joshi-Barve, S, Barve, S, Chen, LH, Barve, S & Chen, LH (2004) Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23, 71–78.
48 Trebble, T, Arden, NK, Stroud, MA, et al. (2003) Inhibition of tumour necrosis factor-α and interleukin-6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Brit J Nutr 90, 405–412.
49 Wallace, FA, Miles, EA & Calder, PC (2003) Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Brit J Nutr 89, 679–689.
50 Cooper, AL, Gibbons, L, Horan, MA, Little, RA & Rothwell, NJ (1993) Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers. Clin Nutr 12, 321–328.
51 Abbate, R, Gori, AM, Martini, F, et al. (1996) n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prostagland Leukotr Essent Fatty Acids 54, 439–444.
52 Gallai, V, Sarchielli, P, Trequattrini, A, et al. (1995) Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol 56, 143–153.
53 Thies, F, Miles, EA, Nebe-von-Caron, G, et al. (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1183–1193.
54 Kew, S, Banerjee, T, Minihane, AM, et al. (2003) Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. Am J Clin Nutr 77, 1287–1295.
55 Miles, EA, Banerjee, T, Dooper, MM, M'Rabet, L, Graus, YM & Calder, PC (2004) The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Brit J Nutr 91, 893–903.
56 Blok, WL, Deslypere, JP, Demacker, PN, et al. (1997) Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur J Clin Invest 27, 1003–1008.
57 Molvig, J, Pociot, F, Worsaae, H, et al. (1991) Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand J Immunol 34, 399–410.
58 Cannon, JG, Fiatarone, MA, Meydani, M, et al. (1995) Aging and dietary modulation of elastase and interleukin-1 beta secretion. Am J Physiol 268, R208–R213.
59 Esperson, GT, Grunnet, N, Lervang, HH, et al. (1992) Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol 11, 393–395.
60 Kremer, JM, Lawrence, DA, Petrillo, GF, et al. (1995) Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs: clinical and immune correlates. Arth Rheum 38, 1107–1114.
61 Adam, O, Beringer, C, Kless, T, et al. (2003) Antiinflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 23, 27–36.
62 Kolahi, S, Ghorbanihaghjo, A, Alizadeh, S, et al. (2010) Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clin Biochem 43, 576–580.
63 Varming, K, Schmidt, EB, Svaneborg, N, et al. (1995) The effect of n-3 fatty acids on neutrophil chemiluminescence. Scand J Clin Lab Invest 55, 47–52.
64 Thompson, PJ, Misso, NLA, Passarelli, M & Phillips, MJ (1991) The effect of eicosapentaenoic acid consumption on human neutrophil chemiluminescence. Lipids 26, 1223–1226.
65 Luostarinen, R & Saldeen, T (1996) Dietary fish oil decreases superoxide generation by human neutrophils: relation to cyclooxygenase pathway and lysosomal enzyme release. Prostagland Leukotr Essent Fatty Acids 55, 167–172.
66 Fisher, M, Levine, PH, Weiner, BH, et al. (1990) Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in monocyte enriched preparation of leukocytes. Am J Clin Nutr 51, 804–808.
67 Schmidt, EB, Varming, K, Moller, JM, Bulow Pederson, I, Madsen, P & Dyerberg, J (1996) No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. Scand J Clin Invest 56, 87–92.
68 Magaro, M, Altomonte, L, Zoli, A, et al. (1988) Influence of diet with different lipid composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid arthritis. Ann Rheum Dis 47, 793–796.
69 Calder, PC & Newsholme, EA (1992) Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clin Sci 82, 695–700.
70 Miles, EA, Banerjee, T, Wells, SJ & Calder, PC (2006) Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males. Nutrition 22, 512–519.
71 Khair-El-Din, TA, Sicher, SC, Vazquez, MA, Wright, WJ & Lu, CY (1995) Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFNγ-induced Ia-expression by murine macrophages in vitro. J Immunol 154, 1296–1306.
72 Hughes, DA, Southon, S & Pinder, AC (1996) (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 126, 603–610.
73 Calder, PC (2007) Polyunsaturated fatty acids alter the rules of engagement. Future Lipidol 2, 27–30.
74 Hughes, DA, Pinder, AC, Piper, Z, Johnson, IT & Lund, EK (1996) Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 63, 267–272.
75 Leslie, CA, Gonnerman, WA, Ullman, MD, et al. (1985) Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med 162, 1336–1339.
76 Volker, DH, FitzGerald, PEB & Garg, ML (2000) The eicosapentaenoic to docosahexaenoic acid ratio of diets affects the pathogenesis of arthritis in Lew/SSN rats. J Nutr 130, 559–565.
77 Ierna, M, Kerr, A, Scales, H, Berge, K & Griinari, M (2010) Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. BMC Musculoskel Disord 11, 136.
78 Fortin, PR, Lew, RA, Liang, MH, et al. (1995) Validation of a metaanalysis: The effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 48, 1379–1390.
80 Goldberg, RJ & Katz, J (2007) A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 129, 210–233.
81 Jadad, AR, Moore, RA, Carroll, D, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Contr Clin Trials 17, 1–12.
82 Belch, JJF, Ansell, D, Madhok, R, O'Dowd, A & Sturrock, RD (1988) Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 47, 96–104.
83 Tullekan, JE, Limburg, PC, Muskiet, FAJ & van Rijswijk, MH (1990) Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis. Arthr Rheum 33, 1416–1419.
84 Skoldstam, L, Borjesson, O, Kjallman, A, Seiving, B & Akesson, B (1992) Effect of six months of fish oil supplementation in stable rheumatoid arthritis: a double blind, controlled study. Scand J Rheumatol 21, 178–185.
85 Nielsen, GL, Faarvang, KL, Thomsen, BS, et al. (1992) The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest 22, 687–691.
86 Kjeldsen-Kragh, J, Lund, JA, Riise, T, et al. (1992) Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis. J Rheumatol 19, 1531–1536.
87 Lau, CS, Morley, KD & Belch, JJF (1993) Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis. Brit J Rheumatol 32, 982–989.
88 Geusens, P, Wouters, C, Nijs, J, Jiang, Y & Dequeker, J (1994) Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arth Rheum 37, 824–829.
89 Volker, D, Fitzgerald, P, Major, G & Garg, M (2000) Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 27, 2343–2346.
90 Remans, PH, Sont, JK, Wagenaar, LW, et al. (2004) Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. Eur J Clin Nutr 58, 839–845.
91 Sundrarjun, T, Komindr, S, Archararit, N, et al. (2004) Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J Int Med Res 32, 443–454.
92 Berbert, AA, Kondo, CR, Almendra, CL, Matsuo, T & Dichi, I (2005) Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 21, 131–136.
93 Galarraga, B, Ho, M, Youssef, HM, et al. (2008) Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatol 47, 665–669.
94 Dawczynski, C, Schubert, R, Hein, G, et al. (2009) Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Brit J Nutr 101, 1517–1526.
95 Das Gupta, AB, Hossain, AKMM, Islam, MH, Dey, SR & Khan, MAL (2009) Role of omega-3 fatty acid supplementation with indomethacin in suppression of disease activity in rheumatoid arthritis. Bangladesh Med Res Counc Bull 35, 63–68.